Gareth Jenkins, CSO at Arcinova, UK, outlines the steps pharma is taking to move towards a data-driven future in this month’s cover feature. In Profession, Robert Dudley, Chairman, CEO, and President of Clarus Therapeutics, discusses the lessons he has learned in a career dedicated to men’s health. And experts from across the industry take time to share their thoughts on how the COVID-19 pandemic is shaping their professional lives in our new Pandemic Diaries series.
June 1, 2020
Richard Bourne’s research group, located at the University of Leeds’ Institute of Process Research and Development, focuses on the optimization of pharmaceutical processes using automated systems. Recently, he has been working on developing automated flow systems that combine online analysis, feedback control, and evolutionary algorithms that help with process understanding and optimization.
0 min read
May 29, 2020
Using green light a catalyst could help scientist conduct safe and cheap reactions
1 min read
May 28, 2020
Secretome engineering eliminates unwanted proteins in CHO-based bioprocessing
1 min read
May 27, 2020
We’re moving towards a data-driven future of enhanced manufacturing. And we must lay the foundations today.
1 min read
May 26, 2020
Sitting Down With… Frédéric Triebel, Co-Founder, Chief Scientific Officer and Chief Medical Officer of Immutep, France
1 min read
May 25, 2020
How fakers are taking advantage of the pandemic
1 min read
May 23, 2020
How immunotherapy could be used to treat infectious diseases
1 min read
May 22, 2020
Gene therapy shows promise for glaucoma in a mouse model
1 min read
May 21, 2020
Robert Dudley, Chairman, CEO and President of Clarus Therapeutics, guided the development of the blockbuster testosterone replacement therapy, AndroGel. Here, Bob reveals his lessons learned and shares how he has tackled the challenges around a newly launched TRT – the first oral softgel approved by the FDA.
1 min read
May 20, 2020
Inhaled administration has the potential to bring benefits to patients – and commercial success to businesses – across a number of therapeutic spaces. But how do you identify the best opportunities for drug repurposing or repositioning?
1 min read
May 19, 2020
We asked medicine makers around the world to tell us how their professional and personal lives have changed during the ongoing COVID-19 crisis.
1 min read
May 18, 2020
A repurposed drug could help improve response rates to immunotherapies
1 min read
May 13, 2020
Announcing the grand winner of The Medicine Maker 2019 Innovation Awards
1 min read
May 13, 2020
Can we reverse the effect of the ageing process on the immune system?
1 min read
May 12, 2020
A clinical trial tracker aims to encourage international collaboration on COVID-19
1 min read
May 11, 2020
Technology transfer can be a challenge with any drug product, but even greater vigilance is needed with more complex formulations, like lipid nanoparticle-based drugs
1 min read
May 5, 2020
COVID-19 clinical trials, lifted bans, and an improving reputation… What’s new in business?
1 min read
May 5, 2020
We must collaborate to address stability challenges in viral vector manufacturing
1 min read
